increase norepinephrine release in vivo,

suggesting that the prostaglandins play a physiologic role

in this process. Thus, vasoconstriction observed during

treatment with COX inhibitors due to increased release of

norepinephrine as well as to inhibition of the endothelial

synthesis of the vasodilators PGE2 and PGI2